openPR Logo
Press release

Digital Therapeutics Sarcopenia Market Analysis Highlights Growth To $3.21 Billion By 2030 At 15.9% CAGR

08-18-2026 11:37 AM CET | Health & Medicine

Press release from: The Business Research Company

Digital Therapeutics Sarcopenia Market

Digital Therapeutics Sarcopenia Market

The field of digital therapeutics for sarcopenia is on the brink of substantial growth, driven by technological advancements and rising healthcare needs related to age-associated muscle loss. As digital tools and personalized treatment approaches gain traction, this sector is poised to make significant strides in managing sarcopenia more effectively. Below is a closer examination of the market's size, leading players, emerging trends, and segmentations that define this evolving landscape.

Projected Market Size and Growth of the Digital Therapeutics Sarcopenia Market
The digital therapeutics sarcopenia market is anticipated to expand swiftly, reaching a valuation of $3.21 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 15.9%. Several factors contribute to this positive outlook, including the rising demand for managing chronic conditions at home, the increasing integration of AI-driven personalized therapies, broader reimbursement policies supporting digital treatments, a surge in remote patient monitoring adoption, and a stronger focus on preventive care targeting muscle health. Key market trends expected during the forecast period involve personalized digital therapy programs, wearable technology for muscle monitoring, remote physiotherapy platforms, data-centric sarcopenia management solutions, and improved patient engagement strategies.

The digital therapeutics sarcopenia market size has grown rapidly in recent years. It will grow from $1.54 billion in 2025 to $1.78 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to rising aging population prevalence, increased awareness of sarcopenia-related health risks, expansion of telehealth adoption, growing acceptance of software-based medical therapies, early clinical validation of digital interventions.

Download a free sample of the digital therapeutics sarcopenia market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27278&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Primary Market Players Leading the Digital Therapeutics Sarcopenia Industry
The digital therapeutics sarcopenia market features several prominent companies that are shaping its direction. Noteworthy names include Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Lark Technologies Inc., Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, Cometa Srl., Koneksa Health Inc., Physitrack PLC, Kaia Health Inc., XRHealth USA Inc., and MedRhythms Inc.

A notable recent development took place in August 2023 when Eli Lilly and Company, a US pharmaceutical giant, acquired Versanis Bio for $1.9 billion. This strategic acquisition adds Versanis' key asset, bimagrumab, to Lilly's portfolio. Bimagrumab is currently undergoing Phase 2b clinical trials both as a standalone treatment and in combination with semaglutide for patients living with overweight or obesity. Versanis Bio, also US-based, specializes in creating therapies targeting sarcopenia, further strengthening Lilly's position in this therapeutic area.

View the full digital therapeutics sarcopenia market report:
https://www.thebusinessresearchcompany.com/report/digital-therapeutics-sarcopenia-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Innovations and Trends Reshaping the Digital Therapeutics Sarcopenia Space
Companies within the digital therapeutics sarcopenia market are actively focusing on the development of cutting-edge solutions such as drug discovery platforms designed to create more precise and effective therapies. These platforms aim to speed up the process of delivering personalized care for muscle loss related to aging.

For example, in April 2025, ProFuse Technology, an Israeli biotech firm, introduced an innovative drug discovery platform that targets muscle loss caused by GLP-1 weight loss drugs, sarcopenia, and cancer cachexia. The technology uses lab-grown, highly mature muscle tissues that closely simulate natural muscle, allowing for rapid and accurate drug testing. This approach helps reduce reliance on animal testing and cuts down research costs. As demand for muscle-preserving treatments rises, ProFuse is expanding its expertise beyond cultivated meat into biopharmaceutical applications, providing a novel solution for tackling muscle health challenges.

Detailed Segment Breakdown in the Digital Therapeutics Sarcopenia Market
The market report categorizes the digital therapeutics sarcopenia sector across several key dimensions:

1) Product Types: Software, Devices, and Services
2) Distribution Channels: Online Platforms, Direct-To-Consumer Digital Channels, and Other Distribution Methods
3) Applications: Muscle Strengthening, Physical Activity Monitoring, Nutrition Management, and Additional Uses
4) End Users: Hospitals and Clinics, Homecare Settings, Rehabilitation Centers, and Other End Users

Further subdivisions within these categories include:
- Software offerings such as mobile apps, web-based platforms, AI-powered monitoring tools, exercise and rehab programs, and nutritional guidance software.
- Devices covering wearable fitness trackers, smart scales, connected resistance bands, electromyography (EMG) instruments, and muscle strength assessment tools.
- Services encompassing remote patient monitoring, virtual physiotherapy, teleconsultation, personalized coaching, and data analytics and reporting.

This segmentation provides a comprehensive framework for understanding the diverse components driving the digital therapeutics sarcopenia market today and into the future.

Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Therapeutics Sarcopenia Market Analysis Highlights Growth To $3.21 Billion By 2030 At 15.9% CAGR here

News-ID: 4606496 • Views:

More Releases from The Business Research Company

Organoids And Spheroids Market Outlook Highlights Strategic Opportunities Across The Industry
Organoids And Spheroids Market Outlook Highlights Strategic Opportunities Across …
The organoids and spheroids market is on the brink of substantial expansion as innovative biotechnologies continue to advance research in life sciences. Increasing investments in personalized medicine and regenerative applications are setting the stage for strong growth over the next decade. Let's explore the market's size, key players, emerging trends, and the primary segments fueling this development. Projected Market Growth and Size of the Organoids and Spheroids Industry The organoids
Oral Solid Dosage Contract Manufacturing Market Study Explores Industry Growth Toward $59.05 Billion
Oral Solid Dosage Contract Manufacturing Market Study Explores Industry Growth T …
The oral solid dosage contract manufacturing sector is on track for significant expansion, driven by increasing demand for outsourced pharmaceutical production and advances in manufacturing technology. As the industry evolves, various factors and trends are shaping its growth trajectory and highlighting key players who are innovating to stay competitive. Let's explore the market size projections, major contributors, emerging trends, and segment details shaping this vital pharmaceutical field. Projected Growth and Size
Oral Expectorant Market Research Reveals Path To $5.36 Billion By 2030
Oral Expectorant Market Research Reveals Path To $5.36 Billion By 2030
The oral expectorant market is showing promising signs of growth as more people seek effective ways to manage respiratory symptoms. With advances in drug formulations and increasing consumer awareness, this sector is set to expand steadily over the coming years. Let's explore the current market size, key players, emerging trends, and detailed segmentation within this evolving industry. Projected Expansion of the Oral Expectorant Market Size by 2030 The oral expectorant
Optical Genome Mapping Market Demonstrates Long-Term Growth Potential At 25.9% CAGR
Optical Genome Mapping Market Demonstrates Long-Term Growth Potential At 25.9% C …
The optical genome mapping market is set to experience remarkable growth in the coming years, driven by technological advancements and expanding applications across clinical and research fields. As the integration of this innovative technology becomes more widespread, the market is positioned for substantial valuation increases and diversified opportunities. Below is a detailed exploration of the market's size, key players, trends, and segment analysis shaping its future. Projected Market Value and Growth

All 5 Releases


More Releases for Digital

Digital luxury brands Market Is Booming Worldwide | Major Giants Balenciaga Digi …
HTF MI recently introduced Global Digital luxury brands Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Major companies in Digital luxury brands Market are: Balenciaga Digital, Louis Vuitton Digital, Gucci Digital, Dolce & Gabbana DGFamily, Prada Virtual,
Introducing Digital Sales Pro, Inc: Revolutionizing Digital Sales in the Digital …
Digital Sales Pro, Inc. is a company that helps content creators and publishers make money from content and reach a larger audience with their craft. In today's world, it can be tough for content creators and publishers to make money and connect with their audience. At, Digital Sales Pro, Inc. we understand these challenges and have created a suite of solutions that help our clients build a strong online presence, monetize
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
Introduction The healthcare industry has seen significant growth and development over the years, with technology playing a critical role in transforming patient care. One such innovative technology that has emerged in recent years is the Global Digital Twin in Healthcare Market. This technology allows healthcare professionals to create a virtual replica of a patient's physical self, enabling them to monitor and analyze patient data in real-time. The Global Digital Twin in
Digital Twin in Healthcare Market Analysis By Type - Product Digital Twins, Proc …
In 2021, the market for Digital Twin in Healthcare worldwide was worth $6.75 billion US dollars. AMR Group projects that the market will reach US$ 96.5 billion by 2031, growing at a CAGR of 40 percent between 2022 and 2031. Industry Overview Digital twins are virtual copies of physical objects or things that data scientist & IT professionals can use to compute simulations prior to developing and deploying the original devices. Digital
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Digital Display Market Future Growth with Worldwide Players (Digital Virgo, Digi …
Digital Display Industry 2019 Global Market 2025 research report represents the historical overview of current Market situation, size, share, trends, growth, supply, outlook and manufacturers with detailed analysis. It also focuses on Digital Display volume and value at global level, regional level and company level. From a global perspective, this report represents overall Digital Display market size by analyzing historical data and future prospect. Get Sample Copy of this Report -